Key facts
- KOVE medical’s last known valuation is $10.4M (Jul 2025).
- It has raised $780K; the latest was Later Stage VC ($620K) in Jul 2025.
- Notable investors include Venture Kick, N & V Capital, Tech4Eva, University of Zürich.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for KOVE medical
- ·The full record, as it builds
Funding rounds
No funding rounds for KOVE medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KOVE medical
Developer of an implantable device designed to close the hole created by the catheter in the fetal membrane during fetoscopy. The company prevents membrane rupture by closing and securing the hole created by the endoscopes used to treat fetuses during pregnancy, enabling doctors to undergo more fetal treatment and reduce the risk of preterm birth.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2019
- Employees
- 7
- Website
- kovemedical.com/
- Ownership
- Privately Held (backing)
KOVE medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KOVE medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KOVE medical in its N-PORT filings yet. We sweep new filings monthly.